Innovative Eyewear Inc. (LUCY) Financial Statements (2024 and earlier)
Company Profile
Business Address |
11900 BISCAYNE BLVD MIAMI, FL 33181 |
State of Incorp. | FL |
Fiscal Year End | December 31 |
Industry (SIC) | 3851 - Ophthalmic Goods (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
6/30/2024 MRQ | 12/31/2023 | 12/31/2022 | |||
---|---|---|---|---|---|
ASSETS | |||||
Current Assets | |||||
Cash, cash equivalents, and short-term investments | 4,287 | 3,591 | |||
Cash and cash equivalents | 4,287 | 3,591 | |||
Receivables | 93 | 110 | |||
Inventory, net of allowances, customer advances and progress billings | 533 | 95 | |||
Inventory | 533 | 95 | |||
Prepaid expense | 314 | 211 | |||
Other current assets | 59 | 36 | |||
Other undisclosed current assets | 330 | 198 | |||
Total current assets: | 5,617 | 4,241 | |||
Noncurrent Assets | |||||
Property, plant and equipment | 133 | 120 | |||
Intangible assets, net (including goodwill) | 286 | 138 | |||
Intangible assets, net (excluding goodwill) | 286 | 138 | |||
Other noncurrent assets | 73 | 82 | |||
Other undisclosed noncurrent assets | 110 | 110 | |||
Total noncurrent assets: | 602 | 449 | |||
TOTAL ASSETS: | 6,219 | 4,690 | |||
LIABILITIES AND EQUITY | |||||
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities, including: | 582 | 276 | |||
Other undisclosed accounts payable and accrued liabilities | 582 | 276 | |||
Deferred revenue | 43 | 30 | |||
Debt | 61 | ||||
Other undisclosed current liabilities | 233 | ||||
Total current liabilities: | 624 | 600 | |||
Noncurrent Liabilities | |||||
Liabilities, other than long-term debt | 35 | 65 | |||
Deferred revenue | 35 | 65 | |||
Total noncurrent liabilities: | 35 | 65 | |||
Total liabilities: | 660 | 665 | |||
Equity | |||||
Equity, attributable to parent | 5,559 | 4,024 | |||
Common stock | 0 | 0 | |||
Additional paid in capital | 22,528 | 14,330 | |||
Accumulated deficit | (16,969) | (10,306) | |||
Total equity: | 5,559 | 4,024 | |||
TOTAL LIABILITIES AND EQUITY: | 6,219 | 4,690 |
Income Statement (P&L) ($ in thousands)
6/30/2024 TTM | 12/31/2023 | 12/31/2022 | ||
---|---|---|---|---|
Revenues | 1,152 | 660 | ||
Cost of revenue | (1,272) | (716) | ||
Gross profit: | (119) | (56) | ||
Operating expenses | (6,736) | (5,520) | ||
Operating loss: | (6,856) | (5,577) | ||
Nonoperating income | 192 | |||
Other nonoperating income | 195 | |||
Interest and debt expense | (3) | (105) | ||
Loss from continuing operations: | (6,666) | (5,682) | ||
Other undisclosed net income | 3 | |||
Net loss available to common stockholders, diluted: | (6,663) | (5,682) |
Comprehensive Income ($ in thousands)
6/30/2024 TTM | 12/31/2023 | 12/31/2022 | ||
---|---|---|---|---|
Net loss: | (6,663) | (5,682) | ||
Comprehensive loss, net of tax, attributable to parent: | (6,663) | (5,682) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.